OCUGAS C3F8
- Risk class
- III
- Product type
- Invasive
- Brand name
- OCUGAS DORC
- Commercial name
- OPHTHALMIC GASES, VITREOUS CAVITY, SULPHUR HEXAFLUORIDE
- Analysis ID
- 2c54db012ef013619a25d540e1c9bca3
- Registration date
- December 07, 2022
- Expiration date
- December 07, 2027
- City
- SOUTHLAND
- Country
- NETHERLANDS
- Address
- SCHEIJDELVEWEG 2, 3214 VN ZUIDLAND
- Name
- D.O.R.C. DUTCH OPHTALMIC RESEARCH CENTER (INTERNATIONAL) B.V. (DORC)
- Country
- NETHERLANDS
- Address
- AV. DE LOS SHYRIS N32-21 AND AV. ELOY ALFARO. CENTRAL PARK BUILDING. 5TH FLOOR. OF. 509
- Phone
- 23801252
INTERMEDIATE TAMPONADE AFTER OPERATIVE TREATMENT OF SEVERE RETINAL DETACHMENT.
Access comprehensive regulatory information for OCUGAS C3F8 in the Ecuador medical device market through Pure Global AI's free database. This III medical device is registered under ARCSA ID 2c54db012ef013619a25d540e1c9bca3 and manufactured by D.O.R.C. DUTCH OPHTALMIC RESEARCH CENTER (INTERNATIONAL) B.V. (DORC). The device was registered on December 07, 2022.
This page provides complete registration details including product type (Invasive), manufacturer information, authorized representative details, and regulatory compliance data from the official Ecuador ARCSA medical device database. Pure Global AI offers free access to Ecuador's complete medical device registry.